JP3931219B2 - Process for producing highly unsaturated fatty acid-containing fats and oils - Google Patents
Process for producing highly unsaturated fatty acid-containing fats and oils Download PDFInfo
- Publication number
- JP3931219B2 JP3931219B2 JP23954997A JP23954997A JP3931219B2 JP 3931219 B2 JP3931219 B2 JP 3931219B2 JP 23954997 A JP23954997 A JP 23954997A JP 23954997 A JP23954997 A JP 23954997A JP 3931219 B2 JP3931219 B2 JP 3931219B2
- Authority
- JP
- Japan
- Prior art keywords
- oils
- acid
- dha
- dpa
- fatty acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000003925 fat Substances 0.000 title claims description 34
- 239000003921 oil Substances 0.000 title claims description 34
- 235000021122 unsaturated fatty acids Nutrition 0.000 title claims description 12
- 150000004670 unsaturated fatty acids Chemical class 0.000 title claims description 12
- 238000000034 method Methods 0.000 title description 8
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 claims description 76
- 235000020669 docosahexaenoic acid Nutrition 0.000 claims description 39
- 229940090949 docosahexaenoic acid Drugs 0.000 claims description 38
- YUFFSWGQGVEMMI-JLNKQSITSA-N (7Z,10Z,13Z,16Z,19Z)-docosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCCCC(O)=O YUFFSWGQGVEMMI-JLNKQSITSA-N 0.000 claims description 34
- 235000021294 Docosapentaenoic acid Nutrition 0.000 claims description 34
- 235000019197 fats Nutrition 0.000 claims description 32
- 244000005700 microbiome Species 0.000 claims description 25
- RMRCNWBMXRMIRW-BYFNXCQMSA-M cyanocobalamin Chemical compound N#C[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O RMRCNWBMXRMIRW-BYFNXCQMSA-M 0.000 claims description 14
- LPNBBFKOUUSUDB-UHFFFAOYSA-N p-toluic acid Chemical compound CC1=CC=C(C(O)=O)C=C1 LPNBBFKOUUSUDB-UHFFFAOYSA-N 0.000 claims description 12
- 241000233671 Schizochytrium Species 0.000 claims description 11
- 238000004519 manufacturing process Methods 0.000 claims description 11
- 238000012258 culturing Methods 0.000 claims description 8
- 229960002104 cyanocobalamin Drugs 0.000 claims description 7
- 235000000639 cyanocobalamin Nutrition 0.000 claims description 7
- 239000011666 cyanocobalamin Substances 0.000 claims description 7
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 claims description 6
- 239000001263 FEMA 3042 Substances 0.000 claims description 6
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 claims description 6
- LRBQNJMCXXYXIU-QWKBTXIPSA-N gallotannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@H]2[C@@H]([C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-QWKBTXIPSA-N 0.000 claims description 6
- 229940033123 tannic acid Drugs 0.000 claims description 6
- 235000015523 tannic acid Nutrition 0.000 claims description 6
- 229920002258 tannic acid Polymers 0.000 claims description 6
- 239000000654 additive Substances 0.000 claims description 3
- 230000000996 additive effect Effects 0.000 claims description 2
- 235000019198 oils Nutrition 0.000 description 31
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 21
- 235000020673 eicosapentaenoic acid Nutrition 0.000 description 16
- 239000000203 mixture Substances 0.000 description 15
- 235000014113 dietary fatty acids Nutrition 0.000 description 11
- 229930195729 fatty acid Natural products 0.000 description 11
- 239000000194 fatty acid Substances 0.000 description 11
- 239000002609 medium Substances 0.000 description 11
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 10
- 150000004665 fatty acids Chemical class 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- 210000004027 cell Anatomy 0.000 description 9
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 9
- 235000021323 fish oil Nutrition 0.000 description 7
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- 238000000926 separation method Methods 0.000 description 6
- 238000004817 gas chromatography Methods 0.000 description 5
- 229910052757 nitrogen Inorganic materials 0.000 description 5
- 238000000746 purification Methods 0.000 description 5
- 239000013535 sea water Substances 0.000 description 5
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 4
- 229940041514 candida albicans extract Drugs 0.000 description 4
- 229910052799 carbon Inorganic materials 0.000 description 4
- 210000004748 cultured cell Anatomy 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- 239000003960 organic solvent Substances 0.000 description 4
- 239000012138 yeast extract Substances 0.000 description 4
- 241000251468 Actinopterygii Species 0.000 description 3
- 229920000064 Ethyl eicosapentaenoic acid Polymers 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- ITNKVODZACVXDS-YNUSHXQLSA-N ethyl (4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoate Chemical compound CCOC(=O)CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CC ITNKVODZACVXDS-YNUSHXQLSA-N 0.000 description 3
- SSQPWTVBQMWLSZ-AAQCHOMXSA-N ethyl (5Z,8Z,11Z,14Z,17Z)-icosapentaenoate Chemical compound CCOC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CC SSQPWTVBQMWLSZ-AAQCHOMXSA-N 0.000 description 3
- VCSQUSNNIFZJAP-AAQCHOMXSA-N ethyl (7Z,10Z,13Z,16Z,19Z)-docosapentaenoate Chemical compound CCOC(=O)CCCCC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CC VCSQUSNNIFZJAP-AAQCHOMXSA-N 0.000 description 3
- 235000019387 fatty acid methyl ester Nutrition 0.000 description 3
- 235000019688 fish Nutrition 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000013028 medium composition Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 208000024827 Alzheimer disease Diseases 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- 241000233675 Thraustochytrium Species 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 239000004202 carbamide Substances 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 238000004440 column chromatography Methods 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 229960005135 eicosapentaenoic acid Drugs 0.000 description 2
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 229940013317 fish oils Drugs 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 239000012046 mixed solvent Substances 0.000 description 2
- YTJSFYQNRXLOIC-UHFFFAOYSA-N octadecylsilane Chemical compound CCCCCCCCCCCCCCCCCC[SiH3] YTJSFYQNRXLOIC-UHFFFAOYSA-N 0.000 description 2
- 235000014593 oils and fats Nutrition 0.000 description 2
- 239000003208 petroleum Substances 0.000 description 2
- 229910052938 sodium sulfate Inorganic materials 0.000 description 2
- 235000011152 sodium sulphate Nutrition 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 150000003626 triacylglycerols Chemical class 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- DVSZKTAMJJTWFG-SKCDLICFSA-N (2e,4e,6e,8e,10e,12e)-docosa-2,4,6,8,10,12-hexaenoic acid Chemical compound CCCCCCCCC\C=C\C=C\C=C\C=C\C=C\C=C\C(O)=O DVSZKTAMJJTWFG-SKCDLICFSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- PAWQVTBBRAZDMG-UHFFFAOYSA-N 2-(3-bromo-2-fluorophenyl)acetic acid Chemical compound OC(=O)CC1=CC=CC(Br)=C1F PAWQVTBBRAZDMG-UHFFFAOYSA-N 0.000 description 1
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- GZJLLYHBALOKEX-UHFFFAOYSA-N 6-Ketone, O18-Me-Ussuriedine Natural products CC=CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O GZJLLYHBALOKEX-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 1
- 239000005695 Ammonium acetate Substances 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 241000555825 Clupeidae Species 0.000 description 1
- 241001147477 Cyclotella cryptica Species 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- PNNNRSAQSRJVSB-SLPGGIOYSA-N Fucose Natural products C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C=O PNNNRSAQSRJVSB-SLPGGIOYSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- JZNWSCPGTDBMEW-UHFFFAOYSA-N Glycerophosphorylethanolamin Natural products NCCOP(O)(=O)OCC(O)CO JZNWSCPGTDBMEW-UHFFFAOYSA-N 0.000 description 1
- 241000003482 Japonochytrium Species 0.000 description 1
- SHZGCJCMOBCMKK-DHVFOXMCSA-N L-fucopyranose Chemical compound C[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@@H]1O SHZGCJCMOBCMKK-DHVFOXMCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 241000294598 Moritella marina Species 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 241001274189 Pomatomus saltatrix Species 0.000 description 1
- 241000598397 Schizochytrium sp. Species 0.000 description 1
- 206010039966 Senile dementia Diseases 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 241001298230 Thraustochytrium sp. Species 0.000 description 1
- 241000607598 Vibrio Species 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 238000005273 aeration Methods 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 238000007605 air drying Methods 0.000 description 1
- 230000037354 amino acid metabolism Effects 0.000 description 1
- 229940043376 ammonium acetate Drugs 0.000 description 1
- 235000019257 ammonium acetate Nutrition 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 229960001040 ammonium chloride Drugs 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000002429 anti-coagulating effect Effects 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 235000013877 carbamide Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- SIHHLZPXQLFPMC-UHFFFAOYSA-N chloroform;methanol;hydrate Chemical compound O.OC.ClC(Cl)Cl SIHHLZPXQLFPMC-UHFFFAOYSA-N 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 229910000365 copper sulfate Inorganic materials 0.000 description 1
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 235000013681 dietary sucrose Nutrition 0.000 description 1
- PXEDJBXQKAGXNJ-QTNFYWBSSA-L disodium L-glutamate Chemical compound [Na+].[Na+].[O-]C(=O)[C@@H](N)CCC([O-])=O PXEDJBXQKAGXNJ-QTNFYWBSSA-L 0.000 description 1
- KAUVQQXNCKESLC-UHFFFAOYSA-N docosahexaenoic acid (DHA) Natural products COC(=O)C(C)NOCC1=CC=CC=C1 KAUVQQXNCKESLC-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 235000004626 essential fatty acids Nutrition 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- -1 fatty acid esters Chemical class 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229960002442 glucosamine Drugs 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 229910000358 iron sulfate Inorganic materials 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- FZWBNHMXJMCXLU-BLAUPYHCSA-N isomaltotriose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)O1 FZWBNHMXJMCXLU-BLAUPYHCSA-N 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 239000012533 medium component Substances 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 238000009629 microbiological culture Methods 0.000 description 1
- 230000001617 migratory effect Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 235000013379 molasses Nutrition 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 235000013923 monosodium glutamate Nutrition 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 125000001477 organic nitrogen group Chemical group 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 description 1
- 150000008104 phosphatidylethanolamines Chemical class 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 1
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 238000012805 post-processing Methods 0.000 description 1
- 229910000160 potassium phosphate Inorganic materials 0.000 description 1
- 235000011009 potassium phosphates Nutrition 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 235000019512 sardine Nutrition 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 229940073490 sodium glutamate Drugs 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 229960004793 sucrose Drugs 0.000 description 1
- 229940045136 urea Drugs 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
Images
Description
【0001】
【発明の属する技術分野】
本発明は、微生物の培養によるドコサヘキサエン酸含有油脂の製造方法に関する。より詳しくは、本発明は、ドコサヘキサエン酸およびドコサペンタエン酸などの高度不飽和脂肪酸を生産する能力を有する微生物を培養してドコサヘキサエン酸含有油脂を製造する際に、該微生物が生産する油脂中に含まれるドコサヘキサエン酸、ドコサペンタエン酸またはエイコサペンタエン酸などの高度不飽和脂肪酸の含有比率をコントロールする方法を提供するものである。
【0002】
【従来の技術】
ドコサヘキサエン酸(以下、「DHA」とも記載する)は、青魚に属する魚油に含まれ、特にイワシやマグロ由来の油には20%前後含まれている。近年、魚油の中でもマグロ眼窩脂肪にはDHAが高濃度で含有されることが発見された。また、脂肪酸の高度精製技術が発達したことなどから、DHAの生理活性機能に関する研究が進展し、コレステロール低下作用、抗血液凝固作用、制癌作用などが明らかとなってきた。さらに、脳代謝系に関連して記憶学習能力の向上、老人性痴呆症の予防、アルツハイマー病の治療などに効果があることが明らかになっている。また、稚魚の成長必須脂肪酸であることも明らかとなっている。このようなことから、DHAは、各種食品あるいは飼料または餌料に使用されている。
【0003】
ドコサペンタエン酸(以下、「DPA」とも記載する)も魚油の中に含まれることが知られているが、その量はごく僅かであるにすぎない。また、DPAの生理活性機能については、未だ不明な点が多く、薬剤を脳へ運び易くする担体として機能することなどが僅かに知られているにすぎない[特開昭61−204136号]。しかし、動物体内でのDHAの不足の代償として、DPAが増加することが知られており[Hometownら、J.Neurochem., vol.51, p.45 (1988);Hammら、Biochem.J., 245, p.907 (1987);および、Rebhungら、Biosci.Biotech.Biochem., vol.58, p.314 (1994)]、DPAが動物体内で何らかの生理的役割を有していることが示唆される。
【0004】
このようなDHAやDPAを魚油から得ようとする場合、その含有率が低い上、魚類の回遊性などの面から魚油が安定な供給源となりにくく、また、魚油特有の異臭があるなどの欠点がある。
【0005】
魚油以外のDHAやDPAの供給源としては、DHAおよびDPA生産能を有する微生物の培養菌体中に蓄積した油脂(微生物オイル)が挙げられる。これらDHAおよびDPA生産能を有する微生物としては、深海から分離された細菌ビブリオ・マリナス(Vibrio marinus)ATCC15381、深海魚の腸内から分離されたビブリオ属細菌、鞭毛菌類であるスラウストキトリウム・アウレウム(Thraustochytrium aureum)ATCC34304、スラウストキトリウム・エスピー(Thraustochytrium sp.)ATCC28211およびATCC20891、シゾキトリウム・エスピー(Schizochytrium sp.)ATCC20888およびATCC20899[米国特許No.5,340,742]、シゾキトリウム属SR21株[Nakaharaら、J.Am.Oil Chem.Soc., Vol.73, p.1421 (1996)]、ジャポノキトリウム・エスピー(Japonochytrium sp.)ATCC28207[特開平1−199588号公報]、微細藻類であるシクロテラ・クリプティカ(Cyclotella cryptica)、クリプテコディニウム・コーニー(Cryptocodenium cohnii)[特開平5−503425号公報]、エミリアニア[特開平5−308978号公報]などが知られている。
【0006】
【発明が解決しようとする課題】
DHAやDPAの供給源としての前記微生物が生産する油脂には、DHA、DPA、エイコサペンタエン酸(以下、「EPA」とも記載する)などの高度不飽和脂肪酸が含有されている。これら高度不飽和脂肪酸の含有比率や生産量は、微生物の種類により異なり、所望の含有比率の油脂を収率良く得ることは困難である。一方、DHA、DPA、EPAなどの高度不飽和脂肪酸含有比率を変化させることができれば、天然の魚油の組成により近くなるばかりか、個々の高度不飽和脂肪酸を分離および精製する操作がより容易なものとなる。
【0007】
【課題を解決するための手段】
本発明者らは、上記課題を解決すべく155種類の化合物について検討した結果、p−トルイル酸、タンニン酸またはシアノコバラミンの存在下にドコサヘキサエン酸およびドコサペンタエン酸生産能を有する微生物を培養することにより、該微生物の産生するDHA含有油脂中のDPAやEPA含量を変化させることができるという知見を得、本発明を完成した。
即ち、本発明は、ドコサヘキサエン酸およびドコサペンタエン酸生産能を有する微生物を培養して高度不飽和脂肪酸含有油脂を製造する方法において、p−トルイル酸、タンニン酸およびシアノコバラミンからなる群から選択される添加剤の存在下に該微生物を培養することを特徴とする高度不飽和脂肪酸含有油脂の製造方法を提供するものである。
【0008】
【発明の実施の形態】
本明細書中に記載した「ドコサヘキサエン酸(DHA)」とは(n−3)系のDHAを、また、「ドコサペンタエン酸(DPA)」とは(n−3)系および/または(n−6)系のDPAを指す。また、本明細書において、「油脂」、「脂質」および「オイル」なる用語は同じ意味で使用する。
【0009】
本発明におけるドコサヘキサエン酸およびドコサペンタエン酸生産能を有する微生物としては、例えば、シゾキトリウム属またはスラウストキトリウム属に属する微生物を挙げることができる。これらの微生物のうち最も好ましいものとしては、シゾキトリウム属SR21株(工業技術院生命工学工業技術研究所に「海生菌SR21菌株」の名称で平成7年3月6日付けで寄託され、受託番号FERM BP−5034を取得している)を挙げることができる。
【0010】
培地中に添加するp−トルイル酸、タンニン酸またはシアノコバラミンの量は、1.0g/L以下であれば良く、0.02〜0.2g/Lの範囲が好ましい。
【0011】
本発明において前記微生物を培養するには、その菌株を予め培養して得られた前培養液を、液体培地または固体培地に接種し、培養する。培地は、天然海水または人工海水、あるいは調製した合成培地であってもよい。
【0012】
培地に添加する炭素源としては、グルコース、フルクトース、キシロース、サッカロース、マルトース、可溶性デンプン、フコース、グルコサミン、デキストランなどの炭水化物の他、オレイン酸、ダイズ油などの油脂類や、グルタミン酸、糖蜜、グリセロール、マンニトール、酢酸ナトリウムなどの一般的に使用されているものをいずれも使用できるが、これらに限られるものではない。
【0013】
窒素源としては、ペプトン、酵母エキス、麦芽エキス、肉エキス、カザミノ酸、コーンスティープリカーなどの天然窒素源、グルタミン酸ナトリウム、尿素などの有機窒素源、または、酢酸アンモニウム、塩化アンモニウム、硝酸アンモニウム、硫酸ナトリウムなどの無機窒素源を用いることができる。
【0014】
この他、必要に応じてリン酸カリウム、リン酸二水素カリウムなどのリン酸塩、硫酸アンモニウム、硫酸ナトリウム、硫酸マグネシウム、硫酸鉄、硫酸銅、塩化カルシウムなどの無機塩およびビタミン類も微量栄養源として使用できる。
【0015】
これらの培地成分は、微生物の生育を害しない濃度であれば特に制限はない。一般的には、炭素源は培地1リットル当たり0.6〜60gの濃度で用いてよい。窒素源は、炭素源の増加に伴って増加させるのが望ましい。
【0016】
培養は、液体培地を用い、フラスコによる振盪培養でも、通気撹拌培養でもできる。通常の撹拌式発酵槽あるいは気泡塔型培養装置を使用することもできる。また、培養温度は20〜40℃の範囲であってよく、培養期間は3〜5日間であるのが望ましい。
【0017】
培養終了後、培養液から遠心分離や濾過などの常用の固液分離手段を用いて培養菌体を得る。菌体を十分に水洗し、好ましくは乾燥する。乾燥は凍結乾燥や風乾などによって行うことができる。
【0018】
このようにして得られる培養菌体を、そのまま動物の飼料や魚類の餌料として用いることができる。また、この菌体から、次のようにしてDHA、DPAおよびEPAなどを含有する油脂を採取することができる。さらに、所望によりDHA、DPAまたはEPAを単離することもできる。
【0019】
油脂の採取は、乾燥菌体を、例えばダイノミルや超音波などにより破砕し、次いで、好ましくは窒素気流下で有機溶媒によって抽出することによって行う。有機溶媒としては、エーテル、ヘキサン、メタノール、エタノール、クロロホルム、ジクロロメタン、石油エーテルなどを用いることができる。また、メタノールと石油エーテルの交互抽出あるいはクロロホルム−メタノール−水の一層系の溶媒を用いる抽出によっても良好な結果を得ることができる。抽出液から減圧下で有機溶媒を留去することにより、高濃度のDHA、DPAおよびEPAを含有する油脂が得られる。
また、上記の方法に代えて、湿菌体を用いて抽出を行うことができる。この場合には、メタノールやエタノールなどの水と相溶性の有機溶媒と水の混合溶媒を使用する。その他の手順は上記と同様である。
【0020】
このようにして得られる油脂中には、DHA、DPAおよびEPAなどの高度不飽和脂肪酸が、中性脂質(例えば、トリグリセリド)または極性脂質(例えば、フォスファチジルコリン、フォスファチジルエタノールアミン、フォスファチジルイノシトール)の形で存在している。培養菌体から採取したDHA、DPAおよびEPA含有油脂からのDHA、DPAおよびEPA含有トリグリセリドの精製は、例えば冷却分離法またはカラムクロマトグラフィー法などにより行うことができる。
【0021】
DHA、DPAおよびEPA含有油脂からのDHA、DPAおよびEPAの分離および精製は、油脂を加水分解し、得られる混合脂肪酸をそのままあるいは混合脂肪酸エステルとした後、常法(例えば、尿素付加法、冷却分離法、カラムクロマトグラフィー法など)により行うことができる。
【0022】
【実施例】
次に、実施例により、本発明をさらに具体的に説明する。
実施例1 シゾキトリウム属微生物による油脂の製造(1)
シゾキトリウム属SR21株について、容量500mlの三角フラスコに、以下の組成の培地100mlを仕込み、以下の条件で撹拌培養を行った。
(1)培地組成(g/L)
1)グルコース:20
2)ポリペプトン:10
3)酵母エキス:5
4)50%人工海水:1L
5)p−トルイル酸:0、0.02、0.05、0.1、0.2
(2)培養条件
1)培養温度(℃):28
2)撹拌数(rpm):100
【0023】
培養後、遠心分離により菌体を集め、105℃で3時間乾燥した。乾燥菌体10mgを10%HClを含むメタノール溶液とジクロロメタンの等量混合液に溶解し、50℃で3時間熱処理することにより、脂肪酸メチルエステルを調製した。これをガスクロマトグラフィーにかけ、脂肪酸組成を分析した。ガスクロマトグラフィーの分離条件を下記に示す。
【0024】
この結果を以下の表1に示す。
【表1】
【0025】
実施例2 シゾキトリウム属微生物による油脂の製造(2)
シゾキトリウム属SR21株について、容量500mlの三角フラスコに、以下の組成の培地100mlを仕込み、実施例1と同条件で撹拌培養を行った。
培地組成(g/L)
1)グルコース:20
2)ポリペプトン:10
3)酵母エキス:5
4)50%人工海水:1L
5)タンニン酸:0.05
培養後、実施例1と同様にして脂肪酸メチルエステルを調製した。これを、実施例1と同条件でガスクロマトグラフィーにかけ、脂肪酸組成を分析した。この結果を図1に示す。
結果からわかるように、タンニン酸を添加したときには、対照と比較して、EPAに相当するピークの減少が認められた。
【0026】
実施例3 シゾキトリウム属微生物による油脂の製造(3)
シゾキトリウム属SR21株について、容量500mlの三角フラスコに、以下の組成の培地100mlを仕込み、実施例1と同条件で撹拌培養を行った。
培地組成(g/L)
1)グルコース:20
2)ポリペプトン:10
3)酵母エキス:5
4)50%人工海水:1L
5)シアノコバラミン:0.05
培養後、実施例1と同様にして脂肪酸メチルエステルを調製した。これを、実施例1と同条件でガスクロマトグラフィーにかけ、脂肪酸組成を分析した。この結果を図1に示す。
結果からわかるように、シアノコバラミンを添加したときには、対照と比較して、奇数鎖脂肪酸である15:0および17:0の割合が減少し、偶数鎖脂肪酸である14:0の割合が増加した。これは、シアノコバラミンがSR21株のアミノ酸代謝に何らかの影響を与え、奇数鎖脂肪酸の前駆体が供給されなくなったためと推定される。
【0027】
実施例4 シゾキトリウム属微生物由来の油脂のカラム精製
実施例1の方法に従い0.2g/Lのp−トルイル酸を含む培地で培養して得た菌体を乾燥して乾燥菌体を得た。この乾燥菌体をクロロホルムとメタノールとの混合溶媒中でガラスビーズを用いて破砕し、濾過した後、ヘキサンで抽出することにより油脂を得た。得られた油脂を、ヘキサン中、水酸化カリウムを含むエタノールの添加によってエステル化した。常法に従って後処理することにより、脂肪酸のエステル体を含む油脂混合物を得た。この油脂混合物は、ガスクロマトグラフィーによる分析によれば、DHAエチルエステルを約50%、DPAエチルエステルを約2.4%、EPAエチルエステルを8.5%含有していた。
【0028】
この油脂混合物につき、下記条件での液体クロマトグラフィーによりDHAエチルエステル、DPAエチルエステルおよびEPAエチルエステルを分離した。即ち、粒子径50μm、細孔径120オングストロームおよび炭素含有率17%のオクタデシルシラン(ODS)充填剤[YMC*GEL ODS-AM-120-S50]を充填した内径400mmおよび長さ2000mmのカラムを用いてHPLCに付した。
上記の油脂混合物1.2kgをメタノール中の10%溶液として上記カラムに導入し、メタノールを使用して4.4リットル/分の流速で溶離し、分画を得た。各分画につき溶媒を留去し、DHAエチルエステル330g、DPAエチルエステル2g、EPAエチルエステル82gを得た。
【0029】
【発明の効果】
本発明に従えば、微生物が産生するDHA含有油脂に含まれる高度不飽和脂肪酸のうち、例えばDPAやEPAの含有比率を変化させることができるので、DHA、DPAおよびEPAの含有比率の異なる培養菌体または油脂を得ることができ、所望により魚油由来のDHA含有油脂組成物と同様の油脂組成物を得ることもできる。
また、微生物培養によって得たDHA含有油脂からDHAを分離および精製するに際し、分離がより困難なDPA含量を減少させることは、DHAの分離および精製を容易にするものである。
【図面の簡単な説明】
【図1】 培地に添加物を加えたときに微生物が産生した油脂中の脂肪酸組成をガスクロマトグラフィーで調べた結果を示すチャートである。[0001]
BACKGROUND OF THE INVENTION
The present invention relates to a method for producing docosahexaenoic acid-containing fats and oils by culturing microorganisms. More specifically, the present invention relates to the fats and oils produced by microorganisms produced by culturing microorganisms capable of producing highly unsaturated fatty acids such as docosahexaenoic acid and docosapentaenoic acid to produce docosahexaenoic acid-containing fats and oils. The present invention provides a method for controlling the content ratio of a highly unsaturated fatty acid such as docosahexaenoic acid, docosapentaenoic acid or eicosapentaenoic acid.
[0002]
[Prior art]
Docosahexaenoic acid (hereinafter also referred to as “DHA”) is contained in fish oils belonging to blue fish, and in particular, it is contained in about 20% in oils derived from sardines and tuna. In recent years, it has been discovered that tuna orbital fat contains a high concentration of DHA among fish oils. In addition, due to the development of advanced fatty acid purification technology, research on the bioactive function of DHA has progressed, and cholesterol lowering action, anticoagulant action, anticancer action, etc. have been clarified. Furthermore, it has been revealed that it is effective in improving memory learning ability, prevention of senile dementia, treatment of Alzheimer's disease, etc. in relation to the brain metabolic system. It has also been revealed that it is a growth essential fatty acid for fry. For this reason, DHA is used in various foods, feeds or feeds.
[0003]
Docosapentaenoic acid (hereinafter also referred to as “DPA”) is also known to be contained in fish oil, but the amount is negligible. Further, the physiologically active function of DPA still has many unclear points, and only a few are known to function as a carrier that facilitates transport of drugs to the brain [Japanese Patent Laid-Open No. 61-204136]. However, it is known that DPA increases as a compensation for the deficiency of DHA in animals [Hometown et al., J. Neurochem., Vol. 51, p. 45 (1988); Hamm et al., Biochem. 245, p.907 (1987); and Rebhung et al., Biosci. Biotech. Biochem., Vol. 58, p. 314 (1994)], that DPA has some physiological role in the animal body. It is suggested.
[0004]
When such DHA or DPA is to be obtained from fish oil, its content is low, and it is difficult for fish oil to be a stable supply source in terms of the migratory properties of fish, and there are also disadvantages such as a strange odor peculiar to fish oil. There is.
[0005]
Examples of the supply source of DHA and DPA other than fish oil include fats and oils (microbe oil) accumulated in cultured cells of microorganisms having DHA and DPA production ability. These microorganisms capable of producing DHA and DPA include Vibrio marinus ATCC15381 isolated from the deep sea, Vibrio bacteria isolated from the intestines of deep sea fish, and Thraustochytrium aureus which is a flagellate fungus. aureum ATCC 34304, Thraustochytrium sp. ATCC 28211 and ATCC 20891, Schizochytrium sp. ATCC 20888 and ATCC 20899 [US Pat. Chem. Soc., Vol. 73, p. 1421 (1996)], Japonochytrium sp. ATCC 28207 [JP-A-1-199588], Cyclotella cryptica, a microalgae, Kripte Kodiniu Known are Cryptocodenium cohnii (JP-A-5-503425), Emilia-Ania (JP-A-5-308978), and the like.
[0006]
[Problems to be solved by the invention]
Oils and fats produced by the microorganism as a source of DHA or DPA contain highly unsaturated fatty acids such as DHA, DPA, and eicosapentaenoic acid (hereinafter also referred to as “EPA”). The content ratio and production amount of these highly unsaturated fatty acids vary depending on the type of microorganism, and it is difficult to obtain fats and oils having a desired content ratio in good yield. On the other hand, if the content ratio of highly unsaturated fatty acids such as DHA, DPA and EPA can be changed, it will not only be closer to the composition of natural fish oil, but it will be easier to separate and purify individual highly unsaturated fatty acids. It becomes.
[0007]
[Means for Solving the Problems]
As a result of studying 155 kinds of compounds to solve the above-mentioned problems, the present inventors cultured microorganisms having docosahexaenoic acid and docosapentaenoic acid producing ability in the presence of p-toluic acid, tannic acid or cyanocobalamin. Thus, the knowledge that the DPA and EPA contents in the DHA-containing oil produced by the microorganism can be changed was obtained, and the present invention was completed.
That is, the present invention is selected from the group consisting of p-toluic acid, tannic acid, and cyanocobalamin in a method for producing highly unsaturated fatty acid-containing fats and oils by culturing microorganisms capable of producing docosahexaenoic acid and docosapentaenoic acid. The present invention provides a method for producing a highly unsaturated fatty acid-containing fat and oil characterized by culturing the microorganism in the presence of an additive.
[0008]
DETAILED DESCRIPTION OF THE INVENTION
As described herein, “docosahexaenoic acid (DHA)” refers to (n-3) -based DHA, and “docosapentaenoic acid (DPA)” refers to (n-3) -based and / or (n -6) Refers to DPA of the system. In the present specification, the terms “oil” and “lipid” and “oil” are used interchangeably.
[0009]
Examples of the microorganism having the ability to produce docosahexaenoic acid and docosapentaenoic acid in the present invention include microorganisms belonging to the genus Schizochytrium or Thraustochytrium. Among these microorganisms, the most preferable one is Schizochytrium SR21 strain (deposited with the name of “marine fungus SR21 strain” at the National Institute of Biotechnology, National Institute of Advanced Industrial Science and Technology as of March 6, 1995. FERM BP-5034).
[0010]
The amount of p-toluic acid, tannic acid or cyanocobalamin added to the medium may be 1.0 g / L or less, and is preferably in the range of 0.02 to 0.2 g / L.
[0011]
In order to culture the microorganisms in the present invention, a preculture solution obtained by culturing the strain in advance is inoculated into a liquid medium or a solid medium and cultured. The medium may be natural seawater or artificial seawater, or a prepared synthetic medium.
[0012]
Carbon sources added to the medium include carbohydrates such as glucose, fructose, xylose, saccharose, maltose, soluble starch, fucose, glucosamine, dextran, fats and oils such as oleic acid and soybean oil, glutamic acid, molasses, glycerol, Commonly used materials such as mannitol and sodium acetate can be used, but are not limited thereto.
[0013]
Nitrogen sources include natural nitrogen sources such as peptone, yeast extract, malt extract, meat extract, casamino acid, corn steep liquor, organic nitrogen sources such as sodium glutamate, urea, or ammonium acetate, ammonium chloride, ammonium nitrate, sodium sulfate An inorganic nitrogen source such as can be used.
[0014]
In addition, mineral salts and vitamins such as phosphates such as potassium phosphate and potassium dihydrogen phosphate, ammonium sulfate, sodium sulfate, magnesium sulfate, iron sulfate, copper sulfate, and calcium chloride are also available as trace nutrients as needed. Can be used.
[0015]
These medium components are not particularly limited as long as they do not harm the growth of microorganisms. In general, the carbon source may be used at a concentration of 0.6 to 60 g per liter of medium. The nitrogen source is desirably increased as the carbon source increases.
[0016]
Cultivation can be carried out using a liquid medium in a shake culture in a flask or aeration and agitation culture. A normal stirred fermenter or bubble column type culture apparatus can also be used. The culture temperature may be in the range of 20 to 40 ° C., and the culture period is preferably 3 to 5 days.
[0017]
After completion of the culture, cultured cells are obtained from the culture solution using conventional solid-liquid separation means such as centrifugation and filtration. The cells are thoroughly washed with water and preferably dried. Drying can be performed by freeze drying or air drying.
[0018]
The cultured cells obtained in this way can be used as they are as animal feed or fish feed. Moreover, the fats and oils containing DHA, DPA, EPA, etc. can be extract | collected from this microbial cell as follows. In addition, DHA, DPA or EPA can be isolated if desired.
[0019]
The oil and fat is collected by crushing the dried cells with, for example, dynomill or ultrasonic waves, and then extracting with an organic solvent, preferably under a nitrogen stream. As the organic solvent, ether, hexane, methanol, ethanol, chloroform, dichloromethane, petroleum ether, or the like can be used. Good results can also be obtained by alternate extraction of methanol and petroleum ether or extraction using a one-layer solvent of chloroform-methanol-water. By distilling off the organic solvent from the extract under reduced pressure, oils and fats containing high concentrations of DHA, DPA and EPA are obtained.
Moreover, it can replace with said method and can extract using a wet cell. In this case, a mixed solvent of water and an organic solvent compatible with water such as methanol or ethanol is used. Other procedures are the same as described above.
[0020]
In the fats and oils thus obtained, highly unsaturated fatty acids such as DHA, DPA and EPA contain neutral lipids (eg triglycerides) or polar lipids (eg phosphatidylcholine, phosphatidylethanolamine, phosphatidase). It exists in the form of fatidylinositol. Purification of DHA, DPA, and EPA-containing triglycerides from DHA, DPA, and EPA-containing fats and oils collected from cultured cells can be performed, for example, by a cooling separation method or a column chromatography method.
[0021]
Separation and purification of DHA, DPA, and EPA from DHA, DPA, and EPA-containing fats and oils can be carried out by hydrolyzing the fats and oils and the resulting mixed fatty acids as they are or mixed fatty acid esters, followed by conventional methods (eg, urea addition method, cooling Separation method, column chromatography method and the like).
[0022]
【Example】
Next, the present invention will be described more specifically with reference to examples.
Example 1 Production of fats and oils by Schizochytrium microorganisms (1)
For Schizochytrium SR21 strain, a 500 ml Erlenmeyer flask was charged with 100 ml of the medium having the following composition and stirred and cultured under the following conditions.
(1) Medium composition (g / L)
1) Glucose: 20
2) Polypeptone: 10
3) Yeast extract: 5
4) 50% artificial seawater: 1L
5) p-Toluic acid: 0, 0.02, 0.05, 0.1, 0.2
(2) Culture conditions 1) Culture temperature (° C): 28
2) Number of stirring (rpm): 100
[0023]
After cultivation, the cells were collected by centrifugation and dried at 105 ° C. for 3 hours. Fatty acid methyl ester was prepared by dissolving 10 mg of dried microbial cells in an equal volume mixture of a methanol solution containing 10% HCl and dichloromethane and heat treating at 50 ° C. for 3 hours. This was subjected to gas chromatography to analyze the fatty acid composition. The separation conditions for gas chromatography are shown below.
[0024]
The results are shown in Table 1 below.
[Table 1]
[0025]
Example 2 Production of fats and oils by Schizochytrium microorganisms (2)
About Schizochytrium SR21 strain | stump | stock, 100 ml of culture media of the following compositions were prepared to the Erlenmeyer flask with a capacity | capacitance of 500 ml, and stirring culture was performed on the same conditions as Example 1. FIG.
Medium composition (g / L)
1) Glucose: 20
2) Polypeptone: 10
3) Yeast extract: 5
4) 50% artificial seawater: 1L
5) Tannic acid: 0.05
After the cultivation, fatty acid methyl ester was prepared in the same manner as in Example 1. This was subjected to gas chromatography under the same conditions as in Example 1 to analyze the fatty acid composition. The result is shown in FIG.
As can be seen from the results, when tannic acid was added, a decrease in the peak corresponding to EPA was observed compared to the control.
[0026]
Example 3 Production of fats and oils by Schizochytrium microorganisms (3)
About Schizochytrium SR21 strain | stump | stock, 100 ml of culture media of the following compositions were prepared to the Erlenmeyer flask with a capacity | capacitance of 500 ml, and stirring culture was performed on the same conditions as Example 1. FIG.
Medium composition (g / L)
1) Glucose: 20
2) Polypeptone: 10
3) Yeast extract: 5
4) 50% artificial seawater: 1L
5) Cyanocobalamin: 0.05
After the cultivation, fatty acid methyl ester was prepared in the same manner as in Example 1. This was subjected to gas chromatography under the same conditions as in Example 1 to analyze the fatty acid composition. The result is shown in FIG.
As can be seen from the results, when cyanocobalamin was added, the ratio of odd chain fatty acids 15: 0 and 17: 0 decreased and the ratio of even chain fatty acids 14: 0 increased compared to the control. This is presumably because cyanocobalamin had some influence on the amino acid metabolism of the SR21 strain, and the precursor of odd-chain fatty acids was not supplied.
[0027]
Example 4 Column purification of fats and oils derived from Schizochytrium microorganisms According to the method of Example 1, cells obtained by culturing in a medium containing 0.2 g / L of p-toluic acid were dried to obtain dry cells. The dried cells were crushed using glass beads in a mixed solvent of chloroform and methanol, filtered, and extracted with hexane to obtain fats and oils. The resulting fat was esterified by the addition of ethanol containing potassium hydroxide in hexane. By post-processing according to a conventional method, an oil and fat mixture containing an ester of fatty acid was obtained. This oil / fat mixture, according to analysis by gas chromatography, contained about 50% DHA ethyl ester, about 2.4% DPA ethyl ester and 8.5% EPA ethyl ester.
[0028]
From this oil / fat mixture, DHA ethyl ester, DPA ethyl ester and EPA ethyl ester were separated by liquid chromatography under the following conditions. That is, using a column having an inner diameter of 400 mm and a length of 2000 mm packed with an octadecylsilane (ODS) filler [YMC * GEL ODS-AM-120-S50] having a particle size of 50 μm, a pore size of 120 Å and a carbon content of 17%. Subjected to HPLC.
1.2 kg of the above oil / fat mixture was introduced into the column as a 10% solution in methanol and eluted at a flow rate of 4.4 liters / minute using methanol to obtain fractions. The solvent was distilled off for each fraction to obtain 330 g of DHA ethyl ester, 2 g of DPA ethyl ester, and 82 g of EPA ethyl ester.
[0029]
【The invention's effect】
According to the present invention, among polyunsaturated fatty acids contained in DHA-containing fats and oils produced by microorganisms, for example, the content ratio of DPA and EPA can be changed, so that cultured bacteria having different content ratios of DHA, DPA and EPA A body or fat can be obtained, and if desired, a fat composition similar to a DHA-containing fat composition derived from fish oil can be obtained.
Further, when separating and purifying DHA from DHA-containing fats and oils obtained by microbial culture, reducing the DPA content, which is more difficult to separate, facilitates the separation and purification of DHA.
[Brief description of the drawings]
FIG. 1 is a chart showing the results of gas chromatographic investigation of the fatty acid composition in fats and oils produced by microorganisms when additives are added to the medium.
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP23954997A JP3931219B2 (en) | 1997-09-04 | 1997-09-04 | Process for producing highly unsaturated fatty acid-containing fats and oils |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP23954997A JP3931219B2 (en) | 1997-09-04 | 1997-09-04 | Process for producing highly unsaturated fatty acid-containing fats and oils |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH1175884A JPH1175884A (en) | 1999-03-23 |
JP3931219B2 true JP3931219B2 (en) | 2007-06-13 |
Family
ID=17046468
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP23954997A Expired - Lifetime JP3931219B2 (en) | 1997-09-04 | 1997-09-04 | Process for producing highly unsaturated fatty acid-containing fats and oils |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP3931219B2 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050019880A1 (en) * | 2003-03-31 | 2005-01-27 | Council Of Scientific And Industrial Research | Method of enhancing levels of polyunsaturated fatty acids in thraustochytrid protists |
JP4813770B2 (en) * | 2004-03-31 | 2011-11-09 | 雅弘 林 | Animal plankton feed and zooplankton culture method using the same |
ES2576986T3 (en) | 2005-06-07 | 2016-07-12 | Dsm Nutritional Products Ag | Eukaryotic microorganisms for the production of lipids and antioxidants |
JP5531324B2 (en) * | 2006-08-01 | 2014-06-25 | ディーエスエム ニュートリショナル プロダクツ アーゲー | Oil-producing microorganism and method for modifying the same |
CN105189740B (en) | 2013-03-13 | 2019-01-15 | 帝斯曼营养品股份公司 | Engineered microorganisms |
JP6573241B2 (en) | 2015-03-18 | 2019-09-11 | 株式会社Ihi | Lipid composition and method for producing the same |
-
1997
- 1997-09-04 JP JP23954997A patent/JP3931219B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
JPH1175884A (en) | 1999-03-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP3538418B2 (en) | Method for producing docosahexaenoic acid and docosapentaenoic acid | |
JP4849806B2 (en) | Method for producing polyunsaturated fatty acids using novel cell treatment method | |
JP4522257B2 (en) | Process for producing transesterified oil or fat or triglyceride | |
JP6169150B2 (en) | Process for producing highly unsaturated fatty acids using novel strain preservation technology | |
US20080269329A1 (en) | Process for Production of Microbial Fat/Oil Containing Discretional Amount of Diacylglycerol and Said Fat/Oil | |
AU2008338017B2 (en) | Method for the cultivation of microorganisms of the order thraustochytriales | |
CA2676556C (en) | Method for increasing the content of docosahexaenoic acid in fat-containing materials or in fats and oils | |
EP0960943A1 (en) | Media for culturing microorganisms and process for producing unsaturated fatty acids or lipids containing the same | |
JP3931219B2 (en) | Process for producing highly unsaturated fatty acid-containing fats and oils | |
JP3995290B2 (en) | Method for producing omega-9 polyunsaturated fatty acid and lipid containing the same | |
WO2001012780A1 (en) | Microorganism secreting out lipid and process for producing the lipid and lipid balls having the lipid encapsulating therein by using the microorganism | |
US20080153142A1 (en) | Process For Producing Triglycerides Constituted By Three Polyunsaturated Fatty Acid Residues of One Type and Utilization Thereof | |
JP2007089522A (en) | Method for producing fatty acid composition containing specific highly unsaturated fatty acid in concentrated state | |
JP5371750B2 (en) | Method for producing DHA-containing phospholipids by microbial fermentation | |
JP4036596B2 (en) | Lipids containing 5,11,14-eicosatrienoic acid and / or 5,11,14,17-eicosatetraenoic acid and method for producing the same | |
JP4036595B2 (en) | Lipids containing n-4 and / or n-7 polyunsaturated fatty acids and method for producing the same | |
JP4079494B2 (en) | Method for producing arachidonic acid and / or eicosapentaenoic acid-containing fats and oils | |
JPH08163990A (en) | Oil-and-fat-containing alga and production of oil-and-fat derived therefrom | |
JP4079978B2 (en) | Lipids containing n-4 and / or n-7 polyunsaturated fatty acids and method for producing the same | |
JP2022000509A (en) | Lipid composition, its use and its production method | |
JP2008307063A (en) | PROCESS FOR PRODUCING ARACHIDONIC ACID-CONTAINING LIPID AND DIHOMO-gamma-LINOLENIC ACID CONTAINING LIPID | |
JP2010042037A (en) | Method for producing triglyceride formed out of three residues of highly unsaturated fatty acid of one kind and utilization of the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20040903 |
|
A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A711 Effective date: 20050929 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20050929 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20061024 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20061222 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20070213 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
S533 | Written request for registration of change of name |
Free format text: JAPANESE INTERMEDIATE CODE: R313533 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
EXPY | Cancellation because of completion of term |